| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Brief Report |
From the Montana Family Medicine Residency Program, Billings
Correspondence: Address correspondence to Renee Crichlow, MD, Montana Family Medicine Residency Program, 123 S. 27th St., Ste. B, Billings, MT 59101 (e-mail: reneec4{at}u.washington.edu)
Abstract
A description of 7 consecutive patients admitted for various forms of neurological impairment. All these patients were found to have cerebrospinal fluid positive for West Nile virus IgM, and routine bacterial cultures were negative. Six of these patients did not present with the typical lymphocytic pleocytosis often quoted when discussing a viral meningitis/encephalitis; rather most presented with a cerebrospinal fluid neutrophilia.
Most discussions regarding the evaluation and diagnosis of neurological infection, including West Nile virus, regard the presence of lymphocytic pleocytosis in cerebrospinal fluid (CSF), as indicative of viral pathogenesis.3, 8–10 We will describe 7 consecutive hospitalized patients presenting with neurological changes in whom the diagnosis of West Nile virus was made. Of these, only 1 patient presented with lymphocytic pleocytosis. Most presented with cerebrospinal fluid neutrophilic pleocytosis more generally associated with bacterial infections of the central nervous system (CNS).9
Case Reports
During July and August of 2003, the Montana Family Medicine Residency admitted a total of 7 patients who were eventually diagnosed with West Nile virus central nervous system infection. The information for this report was collected from retrospective chart review. All patients’ CSF samples were tested at the Montana State Public Health laboratory, in accordance with the CDC criteria for West Nile virus case determination. This lab used an IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) to detect WNV-specific IgM antibody in CSF. IgM antibody in CSF strongly suggests recent CNS infection, because IgM does not readily cross the blood-brain barrier. IgM in serum may persist longer than 500 days after infection, so a single serum IgM is not considered diagnostic, in that it may indicate previous remote West Nile virus exposure.11,12 In addition, routine bacterial cultures were performed for all patients.
The 7 patients studied ranged in age from 24 to 74 years, with a median age of 55 years. There were 4 men and 3 women in the evaluation. All patients lived in south-central Montana except for 1 from northeast Montana. All patients recalled exposure to mosquitoes.
At presentation to the emergency department, all patients complained of headache. Five had symptoms of fever, chills, nausea, and vomiting. Two patients were brought in with decreased levels of consciousness. One patient reported blurry vision (Table 1). One patient presented twice, the first time with headache, fever, and chills. This patient had an initial negative evaluation, including normal CSF cell count. The patient returned again 3 days later with persistent symptoms and an additional complaint of abdominal pain. At this time, repeat evaluation of this patient’s CSF was abnormal and indicative of CNS infection.
|
|
Outcome
Hospital stays ranged from 3 days to greater than 4 weeks with a median of 7 days of inpatient hospitalization. There were no deaths. One patient required ICU admission with short-term ventilator support. Nonetheless, this patient improved rapidly and was discharged from the hospital within 5 days. Six of those admitted to our service were discharged, improved and stable, but still reporting some malaise and weakness, with very delayed improvement. Three of these patients required skilled nursing facilities for rehabilitation from weakness that impaired independent function. Only 1 patient went home with no significant sequela of the West Nile virus meningoencephalitis.
Literature Review
A Medline search with MeSH headings "West Nile virus" and "spinal fluid" demonstrated a trend of West Nile virus infections manifesting cerebrospinal fluid cell count with early neutrophilic pleocytosis as an increasingly common finding10,13–16
Discussion
The 2003 outbreak of West Nile virus brought significant increases in the number of human cases reported in the Rocky Mountain States. Although the majority of people infected with West Nile virus will have a mild illness, those that require hospitalization may have significant long-term impairment.3,6,7 Compared with the previous year, there was an increase in reported cases of more than 100-fold in Montana and more than 150-fold in Colorado.1 As a result of the outbreaks, there has been a greater level of surveillance and vigilance. West Nile virus has become a prominent part of the differential diagnosis for patients presenting with neurological changes.
The cellular content of the cerebrospinal fluid has long been used as an indicator regarding diagnoses and treatment decisions in CNS infections. Our experiences during the summer of 2003 demonstrated that the occurrence or absence of a lymphocytic pleocytosis is not predictive regarding pathogenesis in the presence of West Nile virus CNS infections. Although it is unusual that cerebrospinal fluid cell counts were typical of viral infection in only one of these patients,3,4,8,10,17 other investigators have also noted the possibility of neutrophilic predominance of cerebrospinal fluid pleocytosis in subsets of patients during prior outbreaks of West Nile virus infections.7,10
It has been postulated that this neutrophilic predominance may be more evident earlier in the course of the infection.10 Our overall average from symptom onset to CSF sampling was 3.5 days. The cerebrospinal fluid finding of neutrophilic pleocytosis may be the result of earlier presentation to care by patients and increased vigilance by the medical community during a highly publicized outbreak of West Nile virus. With this in mind, it would seem most prudent for the evaluation of a patient presenting with neurological changes to consist of the full battery of cerebrospinal fluid laboratory tests, including West Nile virus CSF IgM, regardless of the initial cerebrospinal fluid white cell differential.
Received for publication August 9, 2004. Revision received August 9, 2004.
References
This article has been cited by other articles:
|
|
 |
|
  K. L. Tyler, J. Pape, R. J. Goody, M. Corkill, and B. K. Kleinschmidt-DeMasters CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis Neurology, February 14, 2006; 66(3): 361 - 365. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
